Hyung Kon Koh

Title: Inventor Spotlight: Hyung Kon Koh

Introduction

Hyung Kon Koh, a prominent inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology. With a total of three patents to his name, Koh focuses on the innovative development of human granulocyte-colony stimulating factors, which play an essential role in medical therapies for various conditions.

Latest Patents

One of Koh's most notable patents involves a novel physiologically active protein that is a human granulocyte colony-stimulating factor isoform. This innovative construct is designed to enhance the in vivo lifetime of human granulocyte colony-stimulating factors by incorporating a non-protein polymer, polyethylene glycol (PEG). The invention details a specific site within the polypeptide where PEG is bound, ensuring that the protein's functionality remains intact. Furthermore, the patent outlines a pharmaceutical composition that includes genes encoding these isoforms and a primer to modify the amino acid sequence.

Another significant patent in Koh's portfolio describes glycosylated human granulocyte colony-stimulating factor (G-CSF) isoforms. These isoforms feature a modified amino acid sequence that introduces a glycosylation pattern critical for their activity. The patent presents a method for preparing these glycosylated isoforms, emphasizing the process of culturing transformed eukaryotic cells and isolating the resultant proteins, as well as the associated pharmaceutical compositions.

Career Highlights

Throughout his career, Hyung Kon Koh has worked with several prominent companies, notably CJ Corporation and CJ Cheiljedang Corporation. His experience in these organizations has played a significant role in shaping his inventiveness and expertise in his field.

Collaborations

During his professional journey, Koh has collaborated with talented colleagues such as Eun Jung Lee and Hyun Seok Kim. These partnerships have undoubtedly fostered innovation and advancement in their respective projects, contributing to the success of the inventions they have developed together.

Conclusion

Hyung Kon Koh stands out as a noteworthy inventor in the biotechnology sector, with his breakthroughs in granulocyte-colony stimulating factors showcasing the potential for medical advancements. As he continues to innovate and collaborate, Koh's contributions are likely to have lasting impacts on the field and improve therapeutic options for patients worldwide.